Saudi Arabia and France sign economic MoUs worth over $18 billion

(L-R) Panel moderator Eric Chaney of the Institut Montaigne, Saudi Arabia's Minister of Commerce and Investment Dr Majed Al-Qasabi, Saudi Arabia's Minister of Energy, Industry and Mineral Resources Khalid Al-Falih, CEO of French oil giant Total Patrick Pouyanne and BNP Paribas Chairman Jean Lemierre attend the during the Saudi-France CEO Forum in Paris on April 10, 2018. (AFP)
Updated 11 April 2018
Follow

Saudi Arabia and France sign economic MoUs worth over $18 billion

DUBAI: Twenty memorandum's of understanding (MoUs) in energy and transportation sectors worth over $18 billion were signed between France and Saudi Arabia on Monday, Saudi state-news channel Al-Ekhbariya reported.
The companies involved in the MoUs were Saudi Arabia’s SABIC and France’s Schneider Electric and Orange, as well as Saudi Arabia’s Nas Air and France’s Safran.
(Developing)


Saudi hospital pioneers preventive type 1 diabetes treatment

KFSH&RC has introduced a groundbreaking preventive treatment aimed at slowing the progression of type 1 diabetes. (SPA)
Updated 13 sec ago
Follow

Saudi hospital pioneers preventive type 1 diabetes treatment

RIYADH: King Faisal Specialist Hospital and Research Center introduced a groundbreaking preventive treatment aimed at slowing the progression of type 1 diabetes, the Saudi Press Agency reported on Wednesday.
The new therapy is designed for adults and children aged eight years and older who are diagnosed at stage two of the disease. It marks the first time such a treatment has been implemented in the Kingdom.
The initial application involved two patients who met all the criteria outlined in the approved protocol. The step represents a major advance in early preventive care for one of the most common autoimmune conditions affecting children and adolescents.
Both cases were treated at the hospital’s Department of Pediatrics. For families already managing type 1 diabetes, the innovation brings new hope.
Siblings of affected children often face increased risk due to shared genetic and immune factors. Preventive options like this could significantly lower those risks in the future.
The treatment targets the early, pre-type 1 diabetes stage when insulin-producing pancreatic cells begin to deteriorate. Through early intervention, doctors can slow this damage, delay the onset of symptoms and help extend the time before full disease progression.
Implementing the therapy required careful preparation. The drug was compounded in the hospital pharmacy under a precise protocol, while nursing teams received training on administration, monitoring and managing possible reactions.
Medical staff were also briefed on patient selection and follow-up criteria based on the latest clinical guidelines.
According to the SPA, experts expect the program to inspire national research focused on the early stages of the disease and on developing preventive approaches that enhance quality of life for at-risk groups.
KFSH&RC continues to gain recognition on the global stage. It was ranked first in the Middle East and Africa, and 15th worldwide among the top 250 academic medical centers for 2025.
The hospital was also named the most valuable healthcare brand in Saudi Arabia and the Middle East by Brand Finance 2025.
Additionally, Newsweek included KFSH&RC on its lists of the World’s Best Hospitals (2025), the World’s Smartest Hospitals (2026) and the World’s Best Specialized Hospitals (2026).